Castle Biosciences chief commercial officer Tobin W Juvenal reports sale of $108,767.04 in common shares
CSTL•Castle Biosciences Chief Commercial Officer Tobin W. Juvenal sold 3,288 shares on October 26, 2026, at $33.08 per share, leaving him with 45,431 directly owned shares.
1. Share sale
Tobin W. Juvenal sold 3,288 Castle Biosciences common shares on October 26, 2026, at a reported price of $33.08 per share. The sale was valued at $108,767.04, and Juvenal retained 45,431 directly owned shares.
